Govt Job for Pharmacists in ECHS

The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General.

There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).

Ex-Servicemen Contributory Health Scheme (ECHS) invites applications to engage the following vacancies on contractual basis in Ex-Servicemen Contributory Health Scheme Polyclinic, Devlali and Ex-Servicemen Contributory Health Scheme Polyclinic, Dhule for a period of one year.

Post : Pharmacist

No of Post :03 (Devlali-02, Dhule-01)
Age Limit : For Emp-53, For Contractual-55

Basic qualification :
(i) B.Pharmacy from recognized Institute OR
(ii) (10+2) with science stream from Recognized board
(iii) Approved Diploma in Pharmacy from Recongnized by the Pharmacy Council of India and Registered as Pharmacist under the Pharmacy Act 1948

Work Exp : Minimum 3 Year experience
Desirable Attributes : Any diploma / Course in specialist Pharmacy
Salary : Rs 28,100/-

Last date of receipt of application is 18 Mar 2021.

Interview will be conducted on 25 Mar 2021 at 1100 hrs at Station Headquarters Devlali.

Candidates will bring original certificates/degree, photocopy of testimonials and experience certificates as applicable at the time of interview.

Only those individuals will be called for interview who fulfill all the requisite criteria

Related Posts

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad